COMPREHENSIVE TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN USING RESISTOL

Аннотация

We examined 78 children with varying degrees of severity of bronchial asthma at the age of 6-14 years. The first group of patients who received standard basic therapy and a placebo pill (n = 35); the second group of patients (n = 43), who received along with a similar spectrum of basic therapy, was prescribed the drug "Resistol" according to the scheme. The combined use of anti-inflammatory drugs and Resistol gives a pronounced effect in terms of improving the clinical condition of children, normalizing immunological and lymphocytic parameters in patients with bronchial asthma.